Detection of Immune Complex Formation in Non-Clinical Studies and Implications for Clinical Risk Assessment
Authored by: Steven J. Swanson, Ph.D., Executive Director, Clinical Immunology/Medical Sciences, Amgen, Inc.
* - required fields
View All Sponsors
View Media Partners
View 2013 Attendee List
Reducing and Monitoring Bioassay Variability
2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions